AI & IPGlobal
DataMeds AI Interim Co-CEO Details Strategic Vision and Healthcare IP Consolidation Amid Industry Turnaround
DataMeds AI, a healthcare technology company integrating AI and blockchain platforms, has provided a detailed fourth quarter 2026 outlook emphasizing financial discipline, strategic investments, and intellectual property consolidation. Interim Co-CEO Gerald Commissiong highlighted the company’s approach to leveraging…
Tuesday, November 17, 2026